Barbara J Arnold, MD
Ophthalmology · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 58 years
- University of Colorado School of Medicine, Denver, 1968
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Arnold’s office at (916) 525-2020 to ask if they take your plan before you enroll.
California Medical Board record
Licence G24407 · Current
Licensed to practise in California · since 1973 · expires 2028-06-30 · University of Colorado School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$110,129
Medicare paid this office $110,129 for 734 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 467 | $45,977 | $92 |
| New patient visit (45+ min) | 222 | $24,240 | $109 |
| Removal of recurring cataract in lens capsule using a laser | 28 | $8,425 | $272 |
| Laser repair to improve eye fluid flow | 25 | $7,232 | $207 |
| Imaging of retina | 105 | $3,584 | $31 |
See all 11 services
| Return visit (30+ min) | 467 | $45,977 | $92 |
| New patient visit (45+ min) | 222 | $24,240 | $109 |
| Removal of recurring cataract in lens capsule using a laser | 28 | $8,425 | $272 |
| Laser repair to improve eye fluid flow | 25 | $7,232 | $207 |
| Imaging of retina | 105 | $3,584 | $31 |
| Removal of cataract with insertion of prosthetic lens | 55 | $3,440 | $44 |
| Exam of visual field with extended testing | 56 | $3,189 | $51 |
| Short return visit | 52 | $2,497 | $42 |
| Short return visit (20+ min) | 26 | $1,746 | $62 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $392 | $19 |
| Exam of the internal drainage system of eye | 14 | $281 | $20 |
Procedures Medicare counted
| Cataract surgery | 91 | More than 73% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of cataract with insertion of prosthetic lens | 115 | 101 | 70 | 25 | 89 | 78 |
| Removal of recurring cataract in lens capsule using a laser | 63 | 32 | 53 | 52 | 39 | 31 |
| Destruction of growth of retina using a laser | 32 | 24 | 29 | 17 | – | – |
| Laser repair to improve eye fluid flow | – | – | – | – | – | 35 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
734 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 16% · Women 61% · Also on Medicaid 61% · Health risk score 1.46. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 64% · Chronic kidney disease 38% · Coronary heart disease 20% · Depression 16% · Heart failure 14% · COPD 13% · Atrial fibrillation 11% · Cancer 10% · Dementia 8% · Stroke 7%.
The office billed $242,627, Medicare allowed $159,817 and paid $110,129; for 1,211 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 734 | 1,211 | 75 | 1.46 | $242,627 | $110,129 |
| 2023 | 797 | 1,273 | 74 | 1.32 | $252,565 | $106,970 |
| 2022 | 810 | 1,179 | 75 | 1.22 | $256,983 | $108,159 |
| 2021 | 812 | 1,313 | 73 | 1.22 | $385,955 | $146,736 |
| 2020 | 642 | 1,130 | 73 | 1.41 | $385,088 | $129,119 |
| 2019 | 883 | 1,619 | 73 | 1.41 | $506,582 | $184,315 |
| 2018 | 877 | 1,507 | 73 | 1.34 | $479,061 | $162,423 |
| 2017 | 831 | 1,388 | 73 | 1.37 | $483,910 | $165,372 |
| 2016 | 804 | 1,398 | 73 | 1.35 | $524,479 | $157,029 |
| 2015 | 757 | 1,296 | 74 | 1.34 | $536,118 | $168,074 |
| 2014 | 758 | 1,249 | 73 | 1.25 | $506,900 | $169,972 |
| 2013 | 741 | 1,212 | 73 | 1.26 | $516,993 | $161,078 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Return visit (30+ min) | 433 | $39,550 | $85 |
| New patient visit (45+ min) | 333 | $33,353 | $100 |
| Removal of recurring cataract in lens capsule using a laser | 33 | $10,466 | $268 |
| Imaging of retina | 103 | $3,374 | $30 |
| Short return visit | 57 | $3,262 | $43 |
| Removal of cataract with insertion of prosthetic lens | 43 | $3,132 | $50 |
| Exam of visual field with extended testing | 38 | $1,905 | $49 |
| Short return visit (20+ min) | 25 | $1,884 | $70 |
| Removal of cataract with insertion of prosthetic lens | 21 | $1,516 | $58 |
| Imaging of optic nerve | 31 | $722 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 18 | $300 | $15 |
2022: 11 services
| New patient visit (45+ min) | 362 | $36,314 | $100 |
| Return visit (30+ min) | 422 | $35,655 | $80 |
| Removal of recurring cataract in lens capsule using a laser | 43 | $13,422 | $258 |
| Destruction of growth of retina using a laser | 11 | $6,922 | $407 |
| Short return visit | 54 | $2,719 | $41 |
| Short return visit (20+ min) | 26 | $1,969 | $76 |
| Imaging of optic nerve | 70 | $1,869 | $26 |
| Removal of cataract with insertion of prosthetic lens | 20 | $1,551 | $62 |
| Imaging of retina | 42 | $1,447 | $32 |
| Exam of visual field with extended testing | 19 | $919 | $48 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $295 | $18 |
2021: 13 services
| Return visit (30+ min) | 498 | $42,676 | $81 |
| Removal of cataract with insertion of prosthetic lens | 58 | $30,844 | $441 |
| New patient visit (45+ min) | 261 | $27,743 | $106 |
| Removal of recurring cataract in lens capsule using a laser | 45 | $14,299 | $270 |
| Destruction of growth of retina using a laser | 18 | $12,248 | $422 |
| New patient visit (30+ min) | 32 | $2,913 | $91 |
| Imaging of optic nerve | 98 | $2,867 | $28 |
| Short return visit | 45 | $2,288 | $42 |
| Ultrasound scan to determine eye length and lens power | 44 | $2,023 | $45 |
| Short return visit (20+ min) | 26 | $1,688 | $63 |
| Exam of visual field with extended testing | 23 | $1,213 | $53 |
| Imaging of retina | 29 | $861 | $27 |
| Measurement of corneal curvature and depth of eye | 29 | $534 | $18 |
2020: 12 services
| Removal of cataract with insertion of prosthetic lens | 76 | $45,355 | $449 |
| Return visit (30+ min) | 414 | $30,779 | $70 |
| New patient visit (45+ min) | 182 | $18,930 | $104 |
| Destruction of growth of retina using a laser | 13 | $10,482 | $437 |
| Removal of recurring cataract in lens capsule using a laser | 31 | $8,475 | $265 |
| Ultrasound scan to determine eye length and lens power | 60 | $3,000 | $50 |
| Short return visit (20+ min) | 34 | $2,148 | $58 |
| Imaging of optic nerve | 72 | $1,876 | $26 |
| Short return visit | 37 | $1,633 | $32 |
| Exam of visual field with extended testing | 21 | $989 | $47 |
| Measurement of corneal curvature and depth of eye | 41 | $964 | $24 |
| Imaging of retina | 21 | $666 | $30 |
2019: 15 services
| Removal of cataract with insertion of prosthetic lens | 89 | $60,502 | $526 |
| Return visit (30+ min) | 580 | $44,099 | $70 |
| New patient visit (45+ min) | 237 | $24,258 | $102 |
| Removal of recurring cataract in lens capsule using a laser | 55 | $17,408 | $276 |
| Destruction of growth of retina using a laser | 18 | $13,589 | $425 |
| Ultrasound scan to determine eye length and lens power | 94 | $4,859 | $52 |
| Short return visit | 63 | $3,054 | $35 |
| New patient complete exam of visual system | 32 | $3,026 | $95 |
| Imaging of optic nerve | 102 | $2,687 | $26 |
| Short return visit (20+ min) | 48 | $2,509 | $49 |
| Measurement of corneal curvature and depth of eye | 45 | $1,100 | $24 |
| Exam of visual field with limited testing | 29 | $840 | $27 |
| Imaging of retina | 22 | $707 | $31 |
| Exam of visual field with extended testing | 12 | $409 | $34 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $173 | $13 |
2018: 15 services
| Removal of cataract with insertion of prosthetic lens | 88 | $56,849 | $494 |
| Return visit (30+ min) | 529 | $36,207 | $63 |
| New patient visit (45+ min) | 273 | $26,801 | $98 |
| Removal of recurring cataract in lens capsule using a laser | 53 | $15,776 | $254 |
| Destruction of growth of retina using a laser | 11 | $6,570 | $411 |
| Ultrasound scan to determine eye length and lens power | 86 | $4,607 | $53 |
| Imaging of optic nerve | 106 | $2,835 | $25 |
| Short return visit (20+ min) | 51 | $2,615 | $49 |
| New patient complete exam of visual system | 18 | $1,843 | $102 |
| Exam of visual field with extended testing | 33 | $1,566 | $45 |
| Established patient complete exam of visual system | 13 | $979 | $75 |
| Short return visit | 31 | $978 | $26 |
| Imaging of retina | 22 | $712 | $28 |
| Measurement of corneal curvature and depth of eye | 30 | $697 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $486 | $17 |
2017: 12 services
| Removal of cataract with insertion of prosthetic lens | 102 | $67,929 | $519 |
| Return visit (30+ min) | 437 | $31,178 | $69 |
| New patient visit (45+ min) | 210 | $22,246 | $106 |
| Removal of recurring cataract in lens capsule using a laser | 35 | $9,389 | $261 |
| New patient complete exam of visual system | 92 | $7,019 | $76 |
| Ultrasound scan to determine eye length and lens power | 96 | $6,251 | $65 |
| Established patient complete exam of visual system | 56 | $4,152 | $74 |
| Short return visit (20+ min) | 43 | $2,649 | $54 |
| Imaging of optic nerve | 81 | $2,180 | $27 |
| Short return visit | 37 | $1,400 | $32 |
| Exam of visual field with limited testing | 45 | $1,179 | $25 |
| Measurement of corneal curvature and depth of eye | 37 | $954 | $26 |
2016: 14 services
| Removal of cataract with insertion of prosthetic lens | 78 | $54,133 | $511 |
| Return visit (30+ min) | 447 | $31,958 | $67 |
| New patient visit (45+ min) | 272 | $26,643 | $98 |
| Destruction of growth of retina using a laser | 16 | $9,858 | $411 |
| Removal of recurring cataract in lens capsule using a laser | 30 | $8,492 | $257 |
| Ultrasound scan to determine eye length and lens power | 71 | $4,641 | $65 |
| New patient complete exam of visual system | 34 | $3,804 | $112 |
| Destruction of leaking blood vessels of retina using laser | 11 | $3,537 | $272 |
| Short return visit (20+ min) | 48 | $2,868 | $54 |
| Exam of visual field with limited testing | 83 | $1,976 | $23 |
| Established patient complete exam of visual system | 24 | $1,845 | $77 |
| Short return visit | 47 | $1,776 | $31 |
| Imaging of optic nerve | 49 | $1,773 | $35 |
| Measurement of corneal curvature and depth of eye | 46 | $1,074 | $23 |
2015: 15 services
| Removal of cataract with insertion of prosthetic lens | 86 | $60,470 | $521 |
| Return visit (30+ min) | 324 | $25,370 | $72 |
| New patient visit (45+ min) | 163 | $18,571 | $114 |
| New patient complete exam of visual system | 111 | $10,950 | $99 |
| Destruction of growth of retina using a laser | 11 | $9,575 | $416 |
| Established patient complete exam of visual system | 117 | $9,095 | $76 |
| Removal of recurring cataract in lens capsule using a laser | 23 | $6,938 | $267 |
| Ultrasound scan to determine eye length and lens power | 71 | $4,289 | $60 |
| Short return visit (20+ min) | 63 | $3,712 | $52 |
| Exam of visual field with limited testing | 55 | $1,498 | $27 |
| Exam of visual field with extended testing | 42 | $1,495 | $36 |
| Short return visit | 33 | $1,155 | $31 |
| Measurement of corneal curvature and depth of eye | 45 | $1,109 | $25 |
| Photography of the retina | 14 | $924 | $66 |
| Established patient problem focused exam of visual system | 14 | $615 | $44 |
2014: 16 services
| Removal of cataract with insertion of prosthetic lens | 71 | $51,986 | $536 |
| Return visit (30+ min) | 327 | $26,392 | $74 |
| New patient visit (45+ min) | 186 | $20,196 | $109 |
| Destruction of leaking blood vessels of retina using laser | 12 | $14,231 | $837 |
| New patient complete exam of visual system | 116 | $12,238 | $105 |
| Destruction of growth of retina using a laser | 16 | $10,493 | $437 |
| Established patient complete exam of visual system | 108 | $8,742 | $80 |
| Removal of recurring cataract in lens capsule using a laser | 25 | $7,658 | $273 |
| Ultrasound scan to determine eye length and lens power | 65 | $4,486 | $69 |
| Exam of visual field with extended testing | 64 | $3,143 | $49 |
| Short return visit (20+ min) | 48 | $2,724 | $48 |
| Established patient problem focused exam of visual system | 17 | $1,160 | $68 |
| Short return visit | 27 | $1,135 | $34 |
| Photography of the retina | 14 | $928 | $66 |
| Measurement of corneal curvature and depth of eye | 26 | $626 | $24 |
| Ultrasound scan of cornea to determine thickness | 17 | $206 | $12 |
2013: 14 services
| Removal of cataract with insertion of prosthetic lens | 93 | $61,120 | $522 |
| Return visit (30+ min) | 372 | $28,860 | $73 |
| New patient visit (45+ min) | 220 | $24,577 | $112 |
| Destruction of growth of retina using a laser | 17 | $10,153 | $423 |
| New patient complete exam of visual system | 51 | $5,463 | $107 |
| Ultrasound scan to determine eye length and lens power | 73 | $4,613 | $63 |
| Removal of recurring cataract in lens capsule using a laser | 14 | $4,556 | $268 |
| Established patient complete exam of visual system | 46 | $4,071 | $88 |
| Exam of visual field with extended testing | 68 | $3,152 | $45 |
| Short return visit (20+ min) | 57 | $2,858 | $48 |
| Photography of the retina | 19 | $1,146 | $60 |
| Short return visit | 22 | $784 | $31 |
| Measurement of corneal curvature and depth of eye | 32 | $726 | $23 |
| Ultrasound scan of cornea to determine thickness | 32 | $384 | $12 |
Medicaid work
$10,238 in 2024
Medicaid paid $10,238 for 907 billed services this clinician did in 2024, up to 57 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 407 | $6,469 |
| Long return visit (40+ min) | 230 | $1,739 |
| Return visit (30+ min) | 101 | $866 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 125 | $520 |
| New patient visit (45+ min) | 26 | $356 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 18 | $288 |
| 2024 | 907 | 6 | 57 | $10,238 |
| 2023 | 1,126 | 7 | 74 | $3,135 |
| 2022 | 705 | 4 | 52 | $2,211 |
| 2021 | 673 | 5 | 50 | $1,248 |
| 2020 | 596 | 7 | 54 | $8,761 |
| 2019 | 837 | 9 | 48 | $12,315 |
| 2018 | 3,899 | 34 | 61 | $29,733 |
See the largest Medicaid services in earlier years
2023
| New patient visit (45+ min) | 70 | $1,077 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 582 | $1,012 |
| Return visit (30+ min) | 295 | $824 |
| Long return visit (40+ min) | 47 | $126 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 99 | $97 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 13 | $0 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 20 | $0 |
2022
| New patient visit (45+ min) | 81 | $1,464 |
| Return visit (30+ min) | 223 | $707 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 42 | $41 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 359 | $0 |
2021
| Return visit (30+ min) | 324 | $761 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 39 | $343 |
| New patient visit (45+ min) | 43 | $145 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 15 | $0 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 252 | $0 |
2020
| Unclassified drugs | 47 | $4,287 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 74 | $2,976 |
| New patient visit (45+ min) | 58 | $580 |
| Return visit (30+ min) | 233 | $426 |
| Posterior chamber intraocular lens | 12 | $424 |
| Injection, adrenalin, epinephrine, 0.1 mg | 12 | $68 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 160 | $0 |
2019
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 109 | $9,025 |
| Unclassified drugs | 54 | $1,039 |
| New patient visit (45+ min) | 119 | $765 |
| Return visit (30+ min) | 325 | $671 |
| Posterior chamber intraocular lens | 12 | $452 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 163 | $280 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 30 | $61 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 12 | $23 |
| Ophthalmic biometry by A-scan ultrasound echography with intraocular lens power calculation | 13 | $0 |
2018
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 55 | $9,750 |
| New patient visit (45+ min) | 214 | $7,984 |
| Unclassified drugs | 43 | $5,914 |
| Return visit (30+ min) | 313 | $3,255 |
| Posterior chamber intraocular lens | 36 | $2,466 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 49 | $337 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 36 | $27 |
| Medication list documented in medical record (COA) | 108 | $0 |
| BLOOD PRESSURE MEASURED | 35 | $0 |
| WEIGHT RECORDED | 43 | $0 |
| VITAL SIGNS RECORDED | 167 | $0 |
| BODY MASS INDEX DOCD | 166 | $0 |
Drugs they prescribed that Part D paid
$464,896
Pharmacies billed $464,896 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,388) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
627 generic and 761 brand-name prescriptions · $464,896 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Rocklatan | 107 | $82,247 | $769 |
| Lumigan | 105 | $60,245 | $574 |
| Xdemvy | 29 | $54,463 | $1,878 |
| Restasis | 36 | $49,570 | $1,377 |
| Xiidra | 24 | $40,067 | $1,669 |
See all 25 drugs
| Rocklatan | 107 | $82,247 | $769 |
| Lumigan | 105 | $60,245 | $574 |
| Xdemvy | 29 | $54,463 | $1,878 |
| Restasis | 36 | $49,570 | $1,377 |
| Xiidra | 24 | $40,067 | $1,669 |
| Cyclosporine | 39 | $31,415 | $806 |
| Miebo | 15 | $24,416 | $1,628 |
| Rhopressa | 28 | $24,258 | $866 |
| Vyzulta | 28 | $18,022 | $644 |
| Brimonidine | 88 | $9,888 | $112 |
| Cequa | 13 | $8,252 | $635 |
| Simbrinza | 24 | $6,757 | $282 |
| Latanoprost | 293 | $5,596 | $19 |
| Brimonidine Tartrate-Timolol | 26 | $4,740 | $182 |
| Travoprost | 17 | $2,584 | $152 |
| Prednisolone Acetate | 54 | $2,304 | $43 |
| Timolol Maleate | 113 | $1,829 | $16 |
| Ketorolac Tromethamine | 95 | $1,578 | $17 |
| Tobramycin-Dexamethasone | 27 | $1,417 | $52 |
| Valacyclovir | 18 | $909 | $51 |
| Dorzolamide-Timolol | 50 | $732 | $15 |
| Dorzolamide | 22 | $414 | $19 |
| Azelastine | 22 | $276 | $13 |
| Erythromycin | 13 | $276 | $21 |
| Fluticasone Propionate | 11 | $82 | $7 |
Year by year
| 2024 | 1,388 | 341 | 0% (0) | 55% | $464,896 |
| 2023 | 1,238 | 280 | 0% (0) | 62% | $428,094 |
| 2022 | 1,277 | 267 | 0% (0) | 62% | $361,125 |
| 2021 | 1,489 | 309 | 0% (0) | 65% | $338,302 |
| 2020 | 1,378 | 290 | 0% (0) | 61% | $257,340 |
| 2019 | 1,286 | 268 | 0% (0) | 58% | $224,556 |
| 2018 | 1,143 | 259 | 0% (0) | 57% | $183,199 |
| 2017 | 1,168 | 275 | 0% (0) | 61% | $164,753 |
| 2016 | 1,054 | 235 | 0% (0) | 69% | $146,443 |
| 2015 | 996 | 244 | 0% (0) | 69% | $121,073 |
| 2014 | 1,050 | 256 | 0% (0) | 65% | $110,527 |
| 2013 | 1,123 | 295 | 0% (0) | 65% | $102,630 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Rocklatan | 123 | $94,186 | $766 |
| Lumigan | 122 | $80,826 | $663 |
| Restasis | 40 | $50,775 | $1,269 |
| Xiidra | 25 | $45,597 | $1,824 |
| Rhopressa | 49 | $33,898 | $692 |
| Cyclosporine | 17 | $20,002 | $1,177 |
| Brimonidine | 89 | $13,677 | $154 |
| Combigan | 24 | $13,211 | $550 |
| Latanoprost | 360 | $12,319 | $34 |
| Vyzulta | 17 | $11,846 | $697 |
| Brimonidine Tartrate-Timolol | 31 | $8,556 | $276 |
| Simbrinza | 12 | $5,024 | $419 |
| Timolol Maleate | 101 | $4,622 | $46 |
| Brinzolamide | 12 | $4,237 | $353 |
| Travoprost | 12 | $3,352 | $279 |
| Dorzolamide-Timolol | 11 | $2,244 | $204 |
| Prednisolone Acetate | 38 | $1,801 | $47 |
| Tobramycin-Dexamethasone | 21 | $1,471 | $70 |
| Dorzolamide | 26 | $843 | $32 |
| Dorzolamide-Timolol | 17 | $670 | $39 |
| Ketorolac Tromethamine | 16 | $639 | $40 |
| Valacyclovir | 11 | $573 | $52 |
2022: 19 drugs
| Lumigan | 174 | $102,377 | $588 |
| Restasis | 57 | $65,021 | $1,141 |
| Rocklatan | 73 | $41,240 | $565 |
| Rhopressa | 61 | $26,099 | $428 |
| Xiidra | 29 | $25,045 | $864 |
| Combigan | 43 | $20,356 | $473 |
| Brimonidine Tartrate-Timolol | 45 | $13,001 | $289 |
| Latanoprost | 337 | $9,888 | $29 |
| Timolol Maleate | 81 | $5,227 | $65 |
| Brimonidine | 75 | $5,172 | $69 |
| Azopt | 11 | $5,088 | $463 |
| Prednisolone Acetate | 77 | $4,627 | $60 |
| Travoprost | 16 | $4,275 | $267 |
| Valacyclovir | 16 | $1,494 | $93 |
| Tobramycin-Dexamethasone | 13 | $1,029 | $79 |
| Ketorolac Tromethamine | 25 | $859 | $34 |
| Moxifloxacin | 24 | $775 | $32 |
| Dorzolamide-Timolol | 15 | $755 | $50 |
| Dorzolamide | 23 | $754 | $33 |
2021: 17 drugs
| Lumigan | 192 | $88,260 | $460 |
| Restasis | 78 | $85,434 | $1,095 |
| Rocklatan | 82 | $34,265 | $418 |
| Combigan | 70 | $30,968 | $442 |
| Rhopressa | 80 | $27,222 | $340 |
| Prednisolone Acetate | 192 | $12,762 | $66 |
| Latanoprost | 361 | $7,324 | $20 |
| Travoprost | 13 | $4,480 | $345 |
| Brimonidine | 62 | $4,460 | $72 |
| Simbrinza | 14 | $3,066 | $219 |
| Timolol Maleate | 74 | $1,987 | $27 |
| Moxifloxacin | 52 | $1,979 | $38 |
| Valacyclovir | 21 | $1,646 | $78 |
| Dorzolamide-Timolol | 28 | $1,058 | $38 |
| Dorzolamide | 31 | $901 | $29 |
| Tobramycin-Dexamethasone | 11 | $809 | $74 |
| Ofloxacin | 30 | $353 | $12 |
2020: 20 drugs
| Lumigan | 136 | $56,226 | $413 |
| Restasis | 39 | $51,125 | $1,311 |
| Rocklatan | 103 | $36,339 | $353 |
| Combigan | 76 | $27,946 | $368 |
| Prednisolone Acetate | 240 | $15,004 | $63 |
| Rhopressa | 40 | $12,925 | $323 |
| Xiidra | 13 | $7,294 | $561 |
| Zioptan | 14 | $6,953 | $497 |
| Latanoprost | 292 | $5,965 | $20 |
| Travatan Z | 18 | $5,084 | $282 |
| Simbrinza | 26 | $4,632 | $178 |
| Azopt | 11 | $4,042 | $367 |
| Travoprost | 11 | $3,983 | $362 |
| Brimonidine | 36 | $2,451 | $68 |
| Valacyclovir | 18 | $1,700 | $94 |
| Ofloxacin | 111 | $1,415 | $13 |
| Dorzolamide-Timolol | 22 | $920 | $42 |
| Timolol Maleate | 68 | $831 | $12 |
| Dorzolamide | 27 | $689 | $26 |
| Moxifloxacin | 11 | $566 | $51 |
2019: 19 drugs
| Lumigan | 141 | $54,372 | $386 |
| Restasis | 44 | $37,753 | $858 |
| Combigan | 77 | $26,001 | $338 |
| Travatan Z | 39 | $19,581 | $502 |
| Rhopressa | 60 | $15,940 | $266 |
| Prednisolone Acetate | 191 | $12,128 | $63 |
| Rocklatan | 21 | $8,204 | $391 |
| Xiidra | 15 | $8,072 | $538 |
| Azopt | 18 | $6,576 | $365 |
| Latanoprost | 282 | $5,897 | $21 |
| Simbrinza | 30 | $4,992 | $166 |
| Zioptan | 12 | $3,884 | $324 |
| Brimonidine | 38 | $2,707 | $71 |
| Ofloxacin | 101 | $1,452 | $14 |
| Dorzolamide-Timolol | 14 | $914 | $65 |
| Valacyclovir | 18 | $830 | $46 |
| Timolol Maleate | 86 | $816 | $9 |
| Dorzolamide | 29 | $768 | $26 |
| Ketorolac Tromethamine | 15 | $552 | $37 |
2018: 17 drugs
| Lumigan | 165 | $59,873 | $363 |
| Combigan | 77 | $23,259 | $302 |
| Restasis | 30 | $19,473 | $649 |
| Travatan Z | 40 | $17,458 | $436 |
| Azopt | 34 | $10,130 | $298 |
| Restasis Multidose | 15 | $9,719 | $648 |
| Prednisolone Acetate | 161 | $7,639 | $47 |
| Xiidra | 12 | $6,436 | $536 |
| Simbrinza | 24 | $4,943 | $206 |
| Latanoprost | 240 | $4,449 | $19 |
| Brimonidine | 39 | $2,727 | $70 |
| Alphagan P | 11 | $2,472 | $225 |
| Ofloxacin | 89 | $1,255 | $14 |
| Timolol Maleate | 93 | $886 | $10 |
| Dorzolamide | 20 | $439 | $22 |
| Ketorolac Tromethamine | 16 | $389 | $24 |
| Dorzolamide-Timolol | 15 | $325 | $22 |
2017: 16 drugs
| Lumigan | 178 | $63,565 | $357 |
| Travatan Z | 65 | $20,318 | $313 |
| Combigan | 87 | $19,425 | $223 |
| Prednisolone Acetate | 210 | $9,451 | $45 |
| Azopt | 30 | $8,040 | $268 |
| Xiidra | 15 | $6,795 | $453 |
| Restasis | 13 | $6,080 | $468 |
| Simbrinza | 31 | $5,570 | $180 |
| Latanoprost | 214 | $3,220 | $15 |
| Alphagan P | 13 | $2,437 | $187 |
| Ofloxacin | 72 | $1,146 | $16 |
| Timolol Maleate | 83 | $934 | $11 |
| Dorzolamide | 23 | $630 | $27 |
| Ketorolac Tromethamine | 27 | $521 | $19 |
| Dorzolamide-Timolol | 16 | $294 | $18 |
| Brimonidine | 16 | $129 | $8 |
2016: 14 drugs
| Lumigan | 196 | $56,061 | $286 |
| Travatan Z | 87 | $24,379 | $280 |
| Combigan | 90 | $17,407 | $193 |
| Restasis | 17 | $8,212 | $483 |
| Prednisolone Acetate | 173 | $7,435 | $43 |
| Azopt | 29 | $7,320 | $252 |
| Simbrinza | 39 | $6,253 | $160 |
| Alphagan P | 27 | $3,989 | $148 |
| Latanoprost | 134 | $2,203 | $16 |
| Ketorolac Tromethamine | 59 | $1,396 | $24 |
| Dorzolamide | 31 | $928 | $30 |
| Timolol Maleate | 70 | $868 | $12 |
| Ofloxacin | 21 | $331 | $16 |
| Dorzolamide-Timolol | 12 | $210 | $18 |
2015: 16 drugs
| Lumigan | 166 | $37,956 | $229 |
| Travatan Z | 99 | $22,659 | $229 |
| Restasis | 23 | $11,484 | $499 |
| Combigan | 61 | $11,039 | $181 |
| Azopt | 36 | $8,193 | $228 |
| Prednisolone Acetate | 161 | $7,258 | $45 |
| Simbrinza | 46 | $5,647 | $123 |
| Patanol | 14 | $3,359 | $240 |
| Pataday | 11 | $2,339 | $213 |
| Latanoprost | 139 | $1,993 | $14 |
| Alphagan P | 12 | $1,663 | $139 |
| Timolol Maleate | 75 | $702 | $9 |
| Ofloxacin | 39 | $677 | $17 |
| Dorzolamide | 28 | $634 | $23 |
| Ketorolac Tromethamine | 27 | $548 | $20 |
| Dorzolamide-Timolol | 19 | $395 | $21 |
2014: 15 drugs
| Travatan Z | 157 | $28,858 | $184 |
| Lumigan | 130 | $25,251 | $194 |
| Prednisolone Acetate | 171 | $10,326 | $60 |
| Restasis | 19 | $9,789 | $515 |
| Azopt | 39 | $6,895 | $177 |
| Alphagan P | 41 | $6,706 | $164 |
| Combigan | 19 | $3,504 | $184 |
| Latanoprost | 135 | $2,539 | $19 |
| Timolol Maleate | 89 | $2,243 | $25 |
| Brimonidine | 14 | $2,211 | $158 |
| Dorzolamide | 48 | $1,459 | $30 |
| Azelastine | 14 | $1,053 | $75 |
| Dorzolamide-Timolol | 39 | $973 | $25 |
| Ketorolac Tromethamine | 16 | $389 | $24 |
| Ofloxacin | 50 | $378 | $8 |
2013: 18 drugs
| Travatan Z | 165 | $27,603 | $167 |
| Lumigan | 110 | $18,189 | $165 |
| Restasis | 16 | $8,167 | $510 |
| Azopt | 48 | $6,980 | $145 |
| Alphagan P | 42 | $6,414 | $153 |
| Prednisolone Acetate | 159 | $4,963 | $31 |
| Combigan | 22 | $4,345 | $198 |
| Brimonidine | 30 | $3,742 | $125 |
| Latanoprost | 145 | $3,422 | $24 |
| Pataday | 19 | $2,562 | $135 |
| Patanol | 14 | $1,947 | $139 |
| Astepro | 13 | $1,760 | $135 |
| Dorzolamide | 43 | $1,390 | $32 |
| Timolol Maleate | 97 | $1,275 | $13 |
| Dorzolamide-Timolol | 41 | $1,172 | $29 |
| Bacitracin | 14 | $766 | $55 |
| Ofloxacin | 58 | $442 | $8 |
| Ketorolac Tromethamine | 18 | $350 | $19 |
Money from drug and device companies
$1,013 in 2025
| 2025 | 9 | 18 | None | $1,013 |
| 2024 | 8 | 13 | None | $809 |
| 2023 | 7 | 11 | None | $918 |
| 2022 | 6 | 11 | None | $340 |
| 2021 | 5 | 21 | None | $574 |
| 2020 | 4 | 7 | None | $395 |
| 2019 | 7 | 7 | None | $610 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alcon Vision | Rhopressa | $335 | 5 payments
|
| Genentech USA | Susvimo | $150 | 1 payment
|
| Alexion Pharmaceuticals | Ultomiris | $124 | 1 payment
|
| Genentech | Vabysmo | $122 | 1 payment
|
| Apellis Pharmaceuticals | Syfovre | $120 | 1 payment
|
| Abbvie | Lumigan | $81 | 5 payments
|
See all 18 published payments
| Tarsus Pharmaceuticals | Meals · 2025-12-18 | Xdemvy | $18 |
| Bausch & Lomb Americas | Meals · 2025-12-08 | Vyzulta | $21 |
| Alcon Vision | Meals · 2025-11-20 | Rhopressa | $123 |
| Alcon Vision | Meals · 2025-09-26 | Unity | $47 |
| Alcon Vision | Meals · 2025-09-26 | Unity | $20 |
| Alcon Vision | Meals · 2025-09-25 | Rocklatan | $31 |
| Tarsus Pharmaceuticals | Meals · 2025-08-29 | Xdemvy | $24 |
| Amgen | Meals · 2025-08-01 | Tepezza | $18 |
| Apellis Pharmaceuticals | Meals · 2025-06-19 | Syfovre | $120 |
| Genentech USA | Meals · 2025-05-22 | Susvimo | $150 |
| Alexion Pharmaceuticals | Meals · 2025-05-16 | Ultomiris | $124 |
| Abbvie | Meals · 2025-05-02 | Lumigan | $16 |
| Genentech | Meals · 2025-04-17 | Vabysmo | $122 |
| Abbvie | Meals · 2025-04-07 | Lumigan | $15 |
| Abbvie | Meals · 2025-03-21 | Lumigan | $16 |
| Abbvie | Meals · 2025-03-07 | Lumigan | $16 |
| Alcon Vision | Meals · 2025-02-20 | Clareon | $114 |
| Abbvie | Meals · 2025-02-07 | Lumigan | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $809
| Biotissue Holdings | None | $346 | 4 payments
|
| Alcon Vision | Hydrus Microstent | $142 | 3 payments
|
| Genentech USA | Vabysmo | $120 | 1 payment
|
| Apellis Pharmaceuticals | Syfovre | $105 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $28 | 1 payment
|
| Amgen | Tepezza | $27 | 1 payment
|
| Dompe US | Oxervate | $26 | 1 payment
|
| Tarsus Pharmaceuticals | Xdemvy | $16 | 1 payment
|
2023: $918
| Alcon Vision | Centurion | $181 | 3 payments
|
| AbbVie | Durysta | $170 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $146 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $144 | 1 payment
|
| Genentech USA | Vabysmo | $125 | 1 payment
|
| Apellis Pharmaceuticals | None | $120 | 1 payment
|
| Boston Scientific | None | $33 | 1 payment
|
2022: $340
| Genentech USA | Vabysmo | $150 | 1 payment
|
| Alcon Vision | Centurion | $87 | 5 payments
|
| Mallinckrodt Hospital Products | Acthar | $41 | 2 payments
|
| Horizon Therapeutics plc | Tepezza | $26 | 1 payment
|
| Allergan | Vuity | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $15 | 1 payment
|
2021: $574
| Mallinckrodt Hospital Products | Acthar | $302 | 17 payments
|
| Kala Pharmaceuticals | Eysuvis | $119 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $115 | 1 payment
|
| Allergan | Restasis Multidose | $20 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $18 | 1 payment
|
2020: $395
| Allergan | Restasis | $138 | 2 payments
|
| Mallinckrodt Hospital Products | Acthar | $128 | 3 payments
|
| Novartis Pharmaceuticals | Beovu | $110 | 1 payment
|
| Carl Zeiss Meditec AG | None Specified | $19 | 1 payment
|
2019: $610
| Aerie Pharmaceuticals | Rhopressa | $122 | 1 payment
|
| Bausch & Lomb a division of Bausch Health US | Envista | $121 | 1 payment
|
| Novartis Pharmaceuticals | None | $114 | 1 payment
|
| Zimmer Biomet Holdings | Bellatek | $113 | 1 payment
|
| AbbVie | Humira | $87 | 1 payment
|
| Alcon Vision | None | $40 | 1 payment
|
| Sanofi Pasteur | Fluzone Quadrivalent | $13 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 0.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1487701850
- Licence
- CA G24407California G24407: Current · expires 2028-06-30
- Trained
- University of Colorado School of Medicine, Denver, 1968 · 58 years ago
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G244070
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 7551 Timberlake Way, Ste 100, Sacramento, CA, 95823
- NPI first listed
- 2007-01-05
- NPI last updated
- 2007-08-22
This is when the NPI record was last certified, not a medical board exam.